USPTO 2015–2025 USPTO PatentsView US Corporation

Mclaughlin Gormley King Company

USPTO PatentsView assignee record - 27 granted patents across 6 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).

27
Total patents granted
6
CPC technology areas
7.4
Avg claims per patent
+25%
5-year filing velocity

The verdict

Mclaughlin holds 27 US patents across 6 technology areas, rank #11,345 of 50,000 tracked assignees.

#11,345
of 50,000 US assignees by volume
Top 77%
by Innovation Score (27.3/100)
7.4
avg claims per patent
+25%
filing velocity, last 5 yrs

Portfolio overview

McLaughlin Gormley King Company has been granted 27 US utility patents between 2018 and 2024, placing McLaughlin Gormley King Company at rank #11,345 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.4 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a US Corporation, McLaughlin Gormley King Company is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 27.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 15 grants, compared with 12 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. McLaughlin Gormley King Company's 7.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark McLaughlin Gormley King Company against peers pursuing similar technology classes.

How does McLaughlin compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows McLaughlin holds 27 patents, placing it at rank #11,345 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

McLaughlin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

27 Top 77% higher than 23% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). This entry sits in this band. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

02468 2018201920202021202220232024 1
USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
McLaughlin Gormley King Company patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 6 22.2%
2019 6 22.2%
2020 7 25.9%
2021 2 7.4%
2022 4 14.8%
2023 1 3.7%
2024 1 3.7%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Growing

Where it ranks

Overall rank by patents

#11,345

Across all tracked assignees

Innovation Score

27.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does McLaughlin Gormley King Company hold?
McLaughlin Gormley King Company holds 27 US granted patents filed between 2018 and 2024, spanning 6 technology areas.
What is McLaughlin Gormley King Company's Innovation Score?
McLaughlin Gormley King Company has an Innovation Score of 27.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does McLaughlin Gormley King Company focus on?
McLaughlin Gormley King Company's top technology area is A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS) with 27 patents. The company has filed patents in 6 CPC subclasses total.
Is McLaughlin Gormley King Company's patent filing rate increasing or decreasing?
McLaughlin Gormley King Company's recent filing velocity is +25% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for McLaughlin Gormley King Company's patents?
McLaughlin Gormley King Company's patents average 7.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the McLaughlin Gormley King Company patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Mclaughlin's 27 grants land it in the top 77% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Mclaughlin ranks #11,345 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A01N - see who else leads that technology area. A01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov